Corteva, Inc. (CTVA) – What Are Investment Firms Thinking About This Stock?

Corteva, Inc. (NYSE:CTVA – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the twenty-three brokerages that are currently covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, seven have issued a hold recommendation and fifteen have given a buy recommendation to the company. The average 1-year target price among brokers that have issued ratings on the stock in the last year is $52.60.

CTVA has been the subject of several recent research reports. The Goldman Sachs Group reissued a “buy” rating and set a $20.00 target price on shares of Corteva in a research report on Thursday, October 8th. Mizuho set a $16.00 price target on Corteva in a research note on Thursday. Argus reissued a “buy” rating and set a $91.00 price objective on shares of Corteva in a report on Friday, September 18th. Morgan Stanley reissued an “overweight” rating and issued a $18.00 price objective on shares of Corteva in a research note on Friday, October 2nd. Finally, Wall Street Zen lowered Corteva from a “hold” rating to a “sell” rating in a report on Saturday.

Get Our Latest Stock Analysis on CTVA

Hedge Funds Weigh In On Corteva

Large investors have recently bought and sold shares of the stock. EFG International AG purchased a new stake in shares of Corteva in the second quarter valued at about $25,000. Compass Financial Management LLC bought a new stake in Corteva during the second quarter worth $25,000. Elevation Wealth Partners LLC boosted its holdings in shares of Corteva by 334.6% in the 2nd quarter. Elevation Wealth Partners LLC now owns 339 shares of the company’s stock worth $29,000 after buying an additional 261 shares during the last quarter. Clearstead Trust LLC bought a new stake in Corteva in the second quarter worth about $31,000. Finally, N.E.W. Advisory Services LLC purchased a new position in Corteva in the second quarter valued at approximately $33,000. 81.54% of the stock is currently owned by institutional investors.

Key Corteva News

Here’s some of the latest news about CTVA:

  • Neutral Sentiment: Several analysts lowered price targets following the outlook reset. Citigroup and UBS kept neutral ratings, while JPMorgan maintained overweight and RBC kept outperform ratings, signaling some analysts still see potential upside from recent levels. Read More. · Read More. · Read More. · Read More.
  • Negative Sentiment: The earnings miss and lowered full-year outlook are the key near-term headwinds, with Brazil weakness and competitive pricing hurting results. Reuters report on Brazil weakness and forecast cut
  • Negative Sentiment: Law firms announced investigations into potential securities-law violations related to company disclosures. These are allegations under investigation, not findings of wrongdoing, but may add uncertainty for investors. Law firm investigation announcement

Corteva Stock Up 2.4%

Shares of NYSE CTVA traded up $0.23 during midday trading on Friday, hitting $9.41. 28,888,260 shares of the stock traded hands, compared to its average volume of 21,957,566. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.10 and a current ratio of 1.56. Corteva has a one year low of $9.01 and a one year high of $90.97. The business has a 50 day moving average price of $37.22 and a two-hundred day moving average price of $69.57. The company has a market cap of $6.28 billion, a PE ratio of 4.96, a P/E/G ratio of 1.72 and a beta of 0.58.

Corteva Cuts Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Investors of record on Tuesday, December 1st will be issued a dividend of $0.05 per share. This represents a $0.20 annualized dividend and a yield of 2.1%. This is a decrease from Corteva’s previous quarterly dividend of $0.18. The ex-dividend date is Tuesday, December 1st. Corteva’s dividend payout ratio is currently 10.53%.

About Corteva

(Get Free Report)

Corteva, Inc. is an agricultural science company that develops and supplies products and services for farmers. Its business focuses on seeds and crop protection, including technologies intended to help improve crop performance and manage weeds, insects, and plant diseases. Its seed portfolio includes corn, soybean, and other crop varieties, sold under brands such as Pioneer and Brevant. Corteva’s crop protection offerings include herbicides, insecticides, fungicides, and biological products, alongside digital tools and services that support farm decision-making.

See Also

Analyst Recommendations for Corteva (NYSE:CTVA)

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.